Establishment for an effective medical treatment on the basis of the physiological activities of functional mediators involved in the regulation of immunological systems
基于参与免疫系统调节的功能介质的生理活性建立有效的医疗方法
基本信息
- 批准号:10670424
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1. To isolate and identify functional mediators involved in immunological responses, a glycyrrhizin (GL)-affinity column was prepared. Using the GL-affinity column, several GL-binding proteins (gbPs), such as arachidonic acid cascade related enzymes, signal and immunological regulatory factors, were selectively purified from various tissues and rhematoid synovial fluids.2. To characterize potent CK-II inhibitors isolated from medical plants Ed Chinese medicines, the inhibitory effects of these compounds on the CK-II-mediated phosphorylation of functional mediators and viral gene products (HIV-1 RT and PR) were determined in vitro It was found that a glycyrrhetinic acid derivative (oGA) and polyphenol-containing antioxidant compounds (catechin, qercetin and EGCG) function as effective CK-II inhibitors.3. To establish the assay system for evaluation of potent CK-II inhibitors isolated from Chinese medicines and medical plants, the inhibitory effects of the CK-II inhibitors on the physiological activities of the gbPs were determined in vitro. The sensitive assay systems for p96 (lipoxygenase), p54 (hyaluronidase), 31 (HMG-1) and p14 (sLPA2-IIA) in sera of patients had established as useful for clinical diagnosis of microbial inflammation and allergic diseases.
1. 为了分离和鉴定参与免疫反应的功能介质,制备了甘草甜素(GL)亲和柱。利用GL亲和柱,从多种组织和类风湿滑液中选择性纯化了多种GL结合蛋白(gbPs),如花生四烯酸级联相关酶、信号和免疫调节因子。2.为了表征从药用植物和中药中分离出的有效 CK-II 抑制剂,在体外测定了这些化合物对 CK-II 介导的功能介质和病毒基因产物(HIV-1 RT 和 PR)磷酸化的抑制作用。发现甘草次酸衍生物(oGA)和含多酚的抗氧化化合物(儿茶素、槲皮素和EGCG)可作为有效的CK-II抑制剂。3.为了建立从中药和药用植物中分离的强效CK-II抑制剂的测定体系,体外测定CK-II抑制剂对gbPs生理活性的抑制作用。患者血清中 p96(脂氧合酶)、p54(透明质酸酶)、31(HMG-1)和 p14(sLPA2-IIA)的灵敏检测系统已被证实可用于微生物炎症和过敏性疾病的临床诊断。
项目成果
期刊论文数量(33)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ohtsuki, K., Maekawa, T., Harada, S., Karino, A., Morikawa, Y. end Ito, M.: "Biochemical characterization of HIV-1Rev as a potent activator of casein kinase II in vitro"FEBS Letters. 428. 235-240 (1998)
Ohtsuki, K.、Maekawa, T.、Harada, S.、Karino, A.、Morikawa, Y. 和 Ito, M.:“HIV-1Rev 作为酪蛋白激酶 II 体外有效激活剂的生化特征”FEBS Letters
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ohtsuki, K.: "Anti-HIV-1 mechanism of glycyrrhizin"Minopha. Med. Rev.. 45. 1-14 (2000)
Ohtsuki, K.:“甘草甜素的抗 HIV-1 机制”Minopha。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Karino, A., Okano, M., Hatomi, M., Nakamura, T. and Ohtsuki, K.: "Biochemical Characterization of a CK-I-like actin kinase responsible for the actin-induced suppression of CK-II activity in vitro"Biochim. Biophys. Acta. 1472. 603-616 (1999)
Karino, A.、Okano, M.、Hatomi, M.、Nakamura, T. 和 Ohtsuki, K.:“CK-I 样肌动蛋白激酶的生化特征,该激酶负责肌动蛋白诱导的 CK-II 活性抑制
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Abe,Y.et al.: "Characterization of an Apoptosis-induced factor in Habu snake venom as a glycyrrhizin (GL)-binding protein potently inhibited by GL in vitro" Biol.Pharm.Bull.21・9. 924-927 (1998)
Abe, Y. 等人:“Habu 蛇毒中凋亡诱导因子作为甘草酸 (GL) 结合蛋白的特征,在体外受 GL 有效抑制”Biol.Pharm.Bull.21·927( 1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Abe, Y., Shimoyma, S, Munakata, H., Ito, J, Nagata, N., and Ohtsuki, K.: "Characterization of an apoptosis-inducing factor in Habu snake venom as a glyrrhizin (GL)-binding protein potently inhibited by GL in vitro"Biol. Pharm. Bull. 21(9). 924-927 (1998)
Abe, Y.、Shimoyma, S、Munakata, H.、Ito, J、Nagata, N. 和 Ohtsuki, K.:“Habu 蛇毒中凋亡诱导因子作为甘草酸 (GL) 结合蛋白的表征
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OHTSUKI Kenzo其他文献
OHTSUKI Kenzo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OHTSUKI Kenzo', 18)}}的其他基金
Studies on the biochemical characterization of specific mediators for anti-inflammatory and anti-allergic compounds
抗炎抗过敏化合物特异性介质的生化特性研究
- 批准号:
14572098 - 财政年份:2002
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on the mechanisms of the anti-inflammatory and anti-viral native substances
天然抗炎抗病毒物质的作用机制研究
- 批准号:
08670532 - 财政年份:1996
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on the biochemical mechanisms involved in transcriptional regulation and signal transduction during fertilization
受精过程转录调控和信号转导的生化机制研究
- 批准号:
04808026 - 财政年份:1992
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
The study on the biochemical mechanisms involved in the development of embyogensis
胚发生发育的生化机制研究
- 批准号:
02808030 - 财政年份:1990
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
IL-1β信号在dMMR肠癌中介导PD-1单抗耐药及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
Epac/IP3/CREB通路在垂体GH腺瘤细胞内多信号交叉通讯中介导激素过度分泌的机制研究
- 批准号:82173136
- 批准年份:2021
- 资助金额:54.7 万元
- 项目类别:面上项目
CXCL8/CXCR2信号在糖尿病肾病中介导中性粒细胞胞外诱捕网(NETs)致糖萼脱落的功能研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:
发现和研究日本囊对虾中介导弧菌鞭毛蛋白免疫信号的模式识别受体
- 批准号:31873043
- 批准年份:2018
- 资助金额:62.0 万元
- 项目类别:面上项目
孕期轻度砷暴露与学龄前儿童认知损伤及其胎盘甲状腺激素受体信号下调诱导炎症反应的中介作用研究
- 批准号:81803260
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Endocrine tissue molecular pathways dysregulated by immune checkpoint inhibitors causing ICI-triggered adverse events
免疫检查点抑制剂导致内分泌组织分子通路失调,导致 ICI 引发的不良事件
- 批准号:
10648465 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
The role of the tuft cell inflammasome in infection
簇细胞炎症小体在感染中的作用
- 批准号:
10418402 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
The role of the tuft cell inflammasome in infection
簇细胞炎症小体在感染中的作用
- 批准号:
10553185 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Manipulating Neuropeptide Receptors in Mast Cells for Atopic Dermatitis Treatment
操纵肥大细胞中的神经肽受体治疗特应性皮炎
- 批准号:
9302273 - 财政年份:2015
- 资助金额:
$ 2.05万 - 项目类别:
Suppressing inflammation and boosting humoral immunity with n-3 PUFAs
用 n-3 PUFA 抑制炎症并增强体液免疫
- 批准号:
9349651 - 财政年份:2015
- 资助金额:
$ 2.05万 - 项目类别: